Dow Up 0.11% Nasdaq Up 0.50%

Ariad Pharmaceuticals Inc. (ARIA)

-NasdaqGS
6.22 Up 0.06(0.97%) Aug 29, 4:00PM EDT
|After Hours : 6.24 Up 0.02 (0.32%) Aug 29, 7:59PM EDT
Prev Close:6.16
Open:6.16
Bid:6.15 x 12000
Ask:6.30 x 500
1y Target Est:8.72
Beta:1.51
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:6.16 - 6.36
52wk Range:2.15 - 23.00
Volume:3,560,396
Avg Vol (3m):8,057,650
Market Cap:1.16B
P/E (ttm):N/A
EPS (ttm):-1.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARIAUp 0.97%1.16B
NVSUp 0.12%217.97B
PFEUp 0.03%186.36B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.15
Quarterly EPS Est (Sep-14) :-0.30
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback